Andere talen Ikena Oncology, Inc.

Aandelen

IKNA

US45175G1085

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,26 ^USD	+1,61%		-8,70%	-36,04%

12/03	Ikena Oncology, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
21/02	Ikena Oncology, Inc. Kondigt wijzigingen in de leiding aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ikena Oncology : Corporate Presentation - April 2024	16/04
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum	10/04
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum	10/04
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results	12/03
Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
North American Morning Briefing : Inflation Data -2-	12/03
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference	27/02
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer	21/02
Ikena Oncology, Inc. Announces Executive Changes	21/02
Ikena Oncology to Cut 35% of Workforce to Extend Cash Runway Into H2 2026	18/01
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates	18/01
Ikena Oncology, Inc. Provides Corporate Updates	18/01
Top Premarket Decliners	24/11
Ikena Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results	09/11
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results	09/11
Ikena Oncology, Inc. Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial	09/11
Ikena Oncology to Present at Multiple November 2023 Investor Conferences	07/11
Ikena Oncology to Present at Multiple November 2023 Investor Conferences	07/11
North American Morning Briefing : Stocks Look to -2-	06/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ikena Oncology, Inc.

Aandelen

IKNA

US45175G1085

Andere talen

Filters